NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
1.350
+0.040 (3.05%)
Oct 4, 2024, 4:00 PM EDT - Market closed
NextCure Market Cap
NextCure has a market cap or net worth of $37.77 million as of October 4, 2024. Its market cap has increased by 1.25% in one year.
Market Cap
37.77M
Enterprise Value
-42.38M
1-Year Change
1.25%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.50M to $37.77M, a decrease of -91.35%. That is a compound annual growth rate of -36.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 4, 2024 | 37.80M | 18.87% |
| Dec 29, 2023 | 31.80M | -18.88% |
| Dec 30, 2022 | 39.20M | -76.36% |
| Dec 31, 2021 | 165.80M | -44.79% |
| Dec 31, 2020 | 300.30M | -76.57% |
| Dec 31, 2019 | 1.28B | 193.63% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OncoCyte | 38.63M |
| Rapid Micro Biosystems | 38.62M |
| DURECT | 38.49M |
| CareCloud | 38.10M |
| Burning Rock Biotech | 38.06M |
| Protara Therapeutics | 36.93M |
| FibroGen | 36.82M |
| Surrozen | 36.23M |